Russia registers new drug targeting aggressive breast and ovarian cancers
Russia's health ministry has approved 'Elivosa', a new targeted therapy for advanced breast and ovarian cancers, developed with Chinese partners.
We haven't written up this one. Ajel English has the full story — the link below goes straight to it.